Travere Therapeutics, Inc. (0001438533) (Filer) — SEC 8-K Filing
HealthcareOther
Travere Therapeutics
May 11, 2026
Labcorp Completes Crouse Health Lab Asset Acquisition
Closed
HealthcareNew YorkDivestiture
Deal Overview
Labcorp has completed a closed transaction to acquire Crouse Health lab assets. The deal is categorized as a divestiture by the seller and a lab asset acquisition by Labcorp.
The excerpt confirms completion status and the asset focus on lab operations, but it does not provide deal value or financing structure details.
Key Details
- Transaction
- Labcorp acquires Crouse Health lab assets
Filed under
Powered by Tentt
Source healthcare deals in New York for your firm
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
HealthcareOther
Pharvaris
May 11, 2026
A Cancer Driven by Ultra-Rare Mutation Gets Its First FDA-Approved Therapy
HealthcareDivestiture
Partner Therapeutics→Bizengri (bispecific antibody)
May 11, 2026
Oregon ASC to close after acquisition collapses amid state review
HealthcareOregonOther
The Surgery Center of Southern Oregon
May 11, 2026
Mobia Medical CEO eyes large market for stroke rehab
HealthcareCaliforniaOther
Mobia Medical
May 11, 2026